Mutation of which gene is most commonly linked to the development of pancreatic adenocarcinoma?
সমাধান
সঠিক উত্তর: Option B
- The gene most commonly mutated in pancreatic adenocarcinoma is KRAS.
- KRAS is an oncogene that plays a critical role in cell signaling pathways regulating cell growth and differentiation.
- Mutations in KRAS lead to constitutive activation of the protein, promoting uncontrolled cellular proliferation and survival, which contributes to the development and progression of pancreatic adenocarcinoma.
- In fact, activating mutations in KRAS are found in approximately 90% of pancreatic adenocarcinoma cases, making it the hallmark genetic alteration in this malignancy.
While other genes such as TP53, BRCA2, and APC can also be involved in pancreatic cancer, their mutations occur less frequently.
For example:
- TP53 is a tumor suppressor gene and its mutation is common in many cancers, including pancreatic adenocarcinoma, but typically occurs at later stages.
- BRCA2 mutations are associated with hereditary pancreatic cancer syndromes and increase susceptibility but are not as prevalent overall.
- APC is primarily linked to colorectal cancers rather than pancreatic adenocarcinoma.
In summary, the KRAS mutation is the most common and significant genetic alteration in pancreatic adenocarcinoma, often considered an early event in tumorigenesis.
Reference: Robbins Basic Pathology, 10th Edition, Chapter 22: Pancreas (Page 711)
- KRAS is an oncogene that plays a critical role in cell signaling pathways regulating cell growth and differentiation.
- Mutations in KRAS lead to constitutive activation of the protein, promoting uncontrolled cellular proliferation and survival, which contributes to the development and progression of pancreatic adenocarcinoma.
- In fact, activating mutations in KRAS are found in approximately 90% of pancreatic adenocarcinoma cases, making it the hallmark genetic alteration in this malignancy.
While other genes such as TP53, BRCA2, and APC can also be involved in pancreatic cancer, their mutations occur less frequently.
For example:
- TP53 is a tumor suppressor gene and its mutation is common in many cancers, including pancreatic adenocarcinoma, but typically occurs at later stages.
- BRCA2 mutations are associated with hereditary pancreatic cancer syndromes and increase susceptibility but are not as prevalent overall.
- APC is primarily linked to colorectal cancers rather than pancreatic adenocarcinoma.
In summary, the KRAS mutation is the most common and significant genetic alteration in pancreatic adenocarcinoma, often considered an early event in tumorigenesis.
Reference: Robbins Basic Pathology, 10th Edition, Chapter 22: Pancreas (Page 711)